Skip to main content
. 2016 Dec 28;8(4):6970–6983. doi: 10.18632/oncotarget.14344

Table 4. miRNA expressions in the FFPE tissue and pathological characteristics compared with and without recurrence.

Patients with recurrencen=14, (%) Patients without recurrencen=66, (%) Chi-square Multivariate analysis for recurrence 3 yearRFS rate (%) log-rank Multivariate analysis for RFS
P value Odds ratio 95% C.I. P value P value Hazard ratio 95% C.I. P value
let-7d 0.004 0.249 0.004 0.174
 High (n=17) 7 (50.0) 10 (15.2) 70.6
 Low (n=63) 7 (50.0) 56 (84.8) 88.9
let-7e 0.030 0.505 0.339 0.397
 High (n=26) 8 (57.1) 18 (27.3) 76.9
 Low (n=54) 6 (42.9) 48 (72.7) 88.9
miR-26b 0.038 0.153 0.044 0.283
 High (n=37) 10 (71.4) 27 (40.9) 81.1
 Low (n=43) 4 (28.6) 39 (59.1) 90.7
miR-128a 0.038 0.282 0.0438 0.285
 High (n=37) 10 (71.4) 27 (40.9) 81.1
 Low (n=43) 4 (28.6) 39 (59.1) 90.7
miR-148b 0.006 0.173 0.007 0.079
 High (n=42) 12 (85.7) 30 (45.5) 78.6
 Low (n=38) 2 (14.3) 36 (54.5) 94.7
miR-151-5p 0.012 0.341 0.117 0.252
 High (n=28) 9 (64.3) 19 (28.8) 77.2
 Low (n=52) 5 (35.7) 47 (71.2) 89.8
miR-181c 0.001 7.46 1.97 – 28.57 0.003 0.001 4.74 1.66 – 13.51 0.004
 High (n=15) 7 (50.0) 8 (12.1) 66.7
 Low (n=65) 7 (50.0) 58 (87.9) 89.2
miR-361 0.056 0.694 0.076 0.894
 High (n=28) 8 (57.1) 20 (30.3) 79.8
 Low (n=52) 6 (42.9) 46 (69.7) 88.5
Tumor depth 0.048 0.627 0.094 0.150
T4 (n=14) 5 (35.7) 9 (13.6) 75.0
T3 (n=66) 9 (64.3) 57 (86.4) 88.2
Histology 0.022 0.070 0.002 0.066
Muc (n=3) 2 (14.3) 1 (1.5) 33.3
W/D and M/D (n=77) 12 (85.7) 65 (98.5) 88.3

C.I.: confidence interval, W/D: well-differentiated adenocarcinoma, M/D: moderately differentiated adenocarcinoma, Muc: mucinous carcinoma, High: higher expression of miRNA than the threshold, Low: equal or lower expression of miRNA than the threshold. The differences were analyzed by chi-square test, log-rank test or Multivariate logistic regression analysis. P < 0.05 denotes statistically significant difference.